Skip to content

Clinical trials

Phase 2 Carcinoma, Squamous Cell trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Phase: Phase 2 Country / region: Poland Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20111
20121
20152
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Axelar AB1
Boston Scientific Corporation1
Daiichi Sankyo1
Maia Biotechnology1
PCI Biotech AS1
Pfizer1
Replimune, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell8
Head and Neck Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Carcinoma, Non-Small-Cell Lung2
Neoplasms2
Adenocarcinoma1
Adenocarcinoma of Lung1
Carcinoma1
Carcinoma, Large Cell1
Cutaneous Squamous Cell Carcinoma1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.